ASXL1 and DNMT3A mutation in a cytogenetically normal B3 thymoma

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The molecular underpinnings of thymoma remain largely unknown.
• Previous studies identified rare mutations in EGFR and KIT, but common cancer gene mutations were absent.
• Only one prior whole-genome sequence of thymoma has been reported, revealing no known cancer gene mutations.

Purpose of the Study:

• To identify somatic driver mutations in cytogenetically normal thymoma.
• To investigate the genomic landscape of thymoma to understand its genetic etiology.

Main Methods:

• Whole-exome sequencing and low-pass whole-genome sequencing were employed.
• Genomic evaluation of a stage IVB type B3 thymoma sample from a 47-year-old male.
• Analysis focused on identifying somatic point mutations, copy number alterations, and structural variants.

Main Results:

• Mutations in known tumor suppressors DNMT3A (p.G728D) and ASXL1 (p.E657fs) were identified.
• These mutations are consistent with those observed in acute myeloid leukemia.
• The findings challenge the notion that thymoma's genetic basis is distinct from other malignancies.

Conclusions:

• Thymoma may share common molecular drivers with other cancer types.
• Further genomic sequencing of cytogenetically normal thymomas is warranted to uncover specific drivers.
• This study provides new insights into the genetic landscape of thymoma.